English
Specials
Upgrade
Moneycontrol Be a PRO
Moneycontrol PRO
Get App Open
In App
Open App
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Sun Pharma
Sun Pharma
BSE: 524715NSE: SUNPHARMAISIN: INE044A01036

19th-Mar-2023 00:03Source: BSE

Sun Pharmaceutical Industries - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find enclosed herewith our Press Release relating to 'Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata', which we shall be releasing after sending this letter to you. This is for your information and dissemination.

More Announcements on:

27th-Mar-2023 18:25Source: BSE

Sun Pharmaceutical Industries - Closure of Trading Window

26th-Mar-2023 22:40Source: BSE

Sun Pharmaceutical Industries - Further To Our Intimation Filed On 2Nd March 2023, Regarding An Information Technology ('IT') Security Incident, We Wish To Provide An Update.

25th-Mar-2023 19:32Source: BSE

Sun Pharmaceutical Industries - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

19th-Mar-2023 18:45Source: BSE

Sun Pharmaceutical Industries - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

19th-Mar-2023 00:03Source: BSE

Sun Pharmaceutical Industries - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram Teglegram Jio News
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
ISO 27001 - BSI Assurance Mark
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.